Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples